Annual Cash & Cash Equivalents:
$713.83M-$28.47M(-3.84%)Summary
- As of today, DVAX annual cash & cash equivalents is $713.83 million, with the most recent change of -$28.47 million (-3.84%) on December 31, 2024.
- During the last 3 years, DVAX annual cash & cash equivalents has risen by +$167.88 million (+30.75%).
- DVAX annual cash & cash equivalents is now -3.84% below its all-time high of $742.30 million, reached on December 31, 2023.
Performance
DVAX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$647.82M+$34.09M(+5.55%)Summary
- As of today, DVAX quarterly cash & cash equivalents is $647.82 million, with the most recent change of +$34.09 million (+5.55%) on September 30, 2025.
- Over the past year, DVAX quarterly cash & cash equivalents has dropped by -$116.18 million (-15.21%).
- DVAX quarterly cash & cash equivalents is now -15.21% below its all-time high of $763.99 million, reached on September 30, 2024.
Performance
DVAX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DVAX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -3.8% | -15.2% |
| 3Y3 Years | +30.8% | +10.5% |
| 5Y5 Years | +372.6% | +265.7% |
DVAX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -3.8% | +30.8% | -15.2% | +10.5% |
| 5Y | 5-Year | -3.8% | +372.6% | -15.2% | +292.5% |
| All-Time | All-Time | -3.8% | +5971.6% | -15.2% | +2660.4% |
DVAX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $647.82M(+5.6%) |
| Jun 2025 | - | $613.73M(-7.2%) |
| Mar 2025 | - | $661.34M(-7.4%) |
| Dec 2024 | $713.83M(-3.8%) | $713.83M(-6.6%) |
| Sep 2024 | - | $763.99M(+3.9%) |
| Jun 2024 | - | $735.61M(+1.7%) |
| Mar 2024 | - | $723.54M(-2.5%) |
| Dec 2023 | $742.30M(+18.9%) | $742.30M(+3.0%) |
| Sep 2023 | - | $720.42M(+5.7%) |
| Jun 2023 | - | $681.52M(+4.5%) |
| Mar 2023 | - | $651.96M(+4.4%) |
| Dec 2022 | $624.39M(+14.4%) | $624.39M(+6.5%) |
| Sep 2022 | - | $586.49M(+13.2%) |
| Jun 2022 | - | $518.17M(+3.0%) |
| Mar 2022 | - | $503.22M(-7.8%) |
| Dec 2021 | $545.95M(+230.8%) | $545.95M(+31.8%) |
| Sep 2021 | - | $414.15M(+19.8%) |
| Jun 2021 | - | $345.80M(+48.6%) |
| Mar 2021 | - | $232.67M(+41.0%) |
| Dec 2020 | $165.04M(+9.3%) | $165.04M(-6.8%) |
| Sep 2020 | - | $177.16M(-11.7%) |
| Jun 2020 | - | $200.71M(+54.9%) |
| Mar 2020 | - | $129.53M(-14.2%) |
| Dec 2019 | $151.06M(+3.8%) | $151.06M(-13.7%) |
| Sep 2019 | - | $174.95M(+24.5%) |
| Jun 2019 | - | $140.49M(-23.3%) |
| Mar 2019 | - | $183.22M(+25.9%) |
| Dec 2018 | $145.54M(-24.1%) | $145.54M(-19.2%) |
| Sep 2018 | - | $180.22M(-16.6%) |
| Jun 2018 | - | $216.04M(-13.9%) |
| Mar 2018 | - | $250.78M(+30.7%) |
| Dec 2017 | $191.85M(+135.6%) | $191.85M(+0.1%) |
| Sep 2017 | - | $191.68M(+51.0%) |
| Jun 2017 | - | $126.96M(+48.7%) |
| Mar 2017 | - | $85.36M(+4.8%) |
| Dec 2016 | $81.42M(-58.5%) | $81.42M(-25.7%) |
| Sep 2016 | - | $109.55M(-21.2%) |
| Jun 2016 | - | $138.99M(-16.7%) |
| Mar 2016 | - | $166.85M(-14.9%) |
| Dec 2015 | $196.13M(+59.9%) | $196.13M(-11.1%) |
| Sep 2015 | - | $220.70M(+136.3%) |
| Jun 2015 | - | $93.38M(-4.3%) |
| Mar 2015 | - | $97.59M(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $122.65M(-35.2%) | $122.65M(-6.1%) |
| Sep 2014 | - | $130.57M(-15.4%) |
| Jun 2014 | - | $154.31M(-13.2%) |
| Mar 2014 | - | $177.68M(-6.2%) |
| Dec 2013 | $189.38M(+51.3%) | $189.38M(+147.6%) |
| Sep 2013 | - | $76.47M(-14.2%) |
| Jun 2013 | - | $89.16M(-15.4%) |
| Mar 2013 | - | $105.37M(-15.8%) |
| Dec 2012 | $125.13M(+9.8%) | $125.13M(-15.6%) |
| Sep 2012 | - | $148.28M(-7.4%) |
| Jun 2012 | - | $160.20M(+49.9%) |
| Mar 2012 | - | $106.88M(-6.2%) |
| Dec 2011 | $113.96M(+56.5%) | $113.96M(+114.1%) |
| Sep 2011 | - | $53.22M(-13.8%) |
| Jun 2011 | - | $61.72M(+16.0%) |
| Mar 2011 | - | $53.20M(-26.9%) |
| Dec 2010 | $72.81M(+94.7%) | $72.81M(+52.0%) |
| Sep 2010 | - | $47.89M(-17.4%) |
| Jun 2010 | - | $58.01M(+55.1%) |
| Dec 2009 | $37.40M(-45.9%) | $37.40M(-20.6%) |
| Sep 2009 | - | $47.11M(-12.3%) |
| Jun 2009 | - | $53.71M(-22.3%) |
| Dec 2008 | $69.14M(-22.0%) | $69.14M(+6.5%) |
| Sep 2008 | - | $64.94M(+1.8%) |
| Jun 2008 | - | $63.81M(-28.0%) |
| Dec 2007 | $88.66M(+2.4%) | $88.66M(+28.2%) |
| Sep 2007 | - | $69.13M(+44.4%) |
| Jun 2007 | - | $47.89M(-33.2%) |
| Mar 2007 | - | $71.74M(-17.2%) |
| Dec 2006 | $86.60M(+14.7%) | $86.60M(+108.2%) |
| Sep 2006 | - | $41.60M(-38.7%) |
| Mar 2006 | - | $67.90M(-10.1%) |
| Dec 2005 | $75.52M(+14.0%) | $75.52M(+47.7%) |
| Sep 2005 | - | $51.14M(-12.8%) |
| Jun 2005 | - | $58.64M(+1.4%) |
| Mar 2005 | - | $57.83M(-12.7%) |
| Dec 2004 | $66.25M(+125.3%) | $66.25M(-7.4%) |
| Sep 2004 | - | $71.51M(-3.3%) |
| Jun 2004 | - | $73.96M(-1.4%) |
| Mar 2004 | - | $75.01M(+219.6%) |
| Dec 2003 | - | $23.47M |
| Dec 2002 | $29.41M(+150.1%) | - |
| Dec 2001 | $11.76M | - |
FAQ
- What is Dynavax Technologies Corporation annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Dynavax Technologies Corporation?
- What is Dynavax Technologies Corporation annual cash & cash equivalents year-on-year change?
- What is Dynavax Technologies Corporation quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Dynavax Technologies Corporation?
- What is Dynavax Technologies Corporation quarterly cash & cash equivalents year-on-year change?
What is Dynavax Technologies Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of DVAX is $713.83M
What is the all-time high annual cash & cash equivalents for Dynavax Technologies Corporation?
Dynavax Technologies Corporation all-time high annual cash & cash equivalents is $742.30M
What is Dynavax Technologies Corporation annual cash & cash equivalents year-on-year change?
Over the past year, DVAX annual cash & cash equivalents has changed by -$28.47M (-3.84%)
What is Dynavax Technologies Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DVAX is $647.82M
What is the all-time high quarterly cash & cash equivalents for Dynavax Technologies Corporation?
Dynavax Technologies Corporation all-time high quarterly cash & cash equivalents is $763.99M
What is Dynavax Technologies Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, DVAX quarterly cash & cash equivalents has changed by -$116.18M (-15.21%)